Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-08

Clinical Trial Update: To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the interaction between sunitinib and ketoconazole with the aim of reducing the sunitinib dose and cost; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NIZORAL (Ketoconazole)
  • Sutent (sunitinib)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Cancer | Phase 1 | Status: COMPLETED